| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||
Net income (loss) | ||||||||
265 | - | - | - | -5,452 | - | - | - | - |
Net income | ||||||||
- | - | - | - | - | - | 518 | 689 | 220 |
Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||||||||
Depreciation, including patient equipment depreciation | ||||||||
16,740 | - | - | - | 14,971 | - | - | - | - |
Equity-based compensation | ||||||||
2,222 | - | - | - | 5,223 | - | - | - | - |
Deferred income tax | ||||||||
479 | - | - | - | 1,483 | - | - | - | - |
Change in fair value of interest rate swaps, net of reclassification adjustment | ||||||||
707 | - | - | - | -2,702 | - | - | - | - |
Change in fair value of contingent consideration | ||||||||
2,000 | - | - | - | - | - | - | - | - |
Amortization of deferred financing costs | ||||||||
391 | - | - | - | 136 | - | - | - | - |
Write-off of deferred financing costs | ||||||||
- | - | - | - | 2,121 | - | - | - | - |
Gain on sale of investment | ||||||||
590 | - | - | - | - | - | - | - | - |
Interest income in cash and marketable securities held in Trust Account | ||||||||
- | - | - | - | - | - | 1,204 | 1,156 | 364 |
Changes in operating assets and liabilities, net of effects from acquisitions: | ||||||||
Accounts receivable | ||||||||
20,457 | - | - | - | 8,636 | - | - | - | - |
Inventory | ||||||||
-51 | - | - | - | 161 | - | - | - | - |
Prepaid and other assets | ||||||||
-3,908 | - | - | - | 172 | - | - | - | - |
Accounts payable and accrued expenses | ||||||||
24,076 | - | - | - | 4,015 | - | - | - | - |
Prepaid expenses | ||||||||
- | - | - | - | - | - | -47 | 88 | 199 |
Accounts payable | ||||||||
- | - | - | - | - | - | 0 | 12 | -58 |
Accrued expenses | ||||||||
- | - | - | - | - | - | 233 | 20 | -51 |
Accrued expenses - related parties | ||||||||
- | - | - | - | - | - | - | - | 2 |
Income tax payable | ||||||||
- | - | - | - | - | - | - | - | 72 |
Net cash provided by operating activities | ||||||||
24,380 | 62,191 | -606 | -17,399 | 16,232 | 69,696 | -356 | -533 | -380 |
Cash flows from investing activities: | ||||||||
Purchases of equipment and other fixed assets | ||||||||
7,534 | - | - | - | 5,297 | - | - | - | - |
Proceeds from sale of investment | ||||||||
2,045 | - | - | - | - | - | - | - | - |
Payments for business acquisitions, net of cash acquired | ||||||||
105,840 | - | - | - | 20,881 | - | - | - | - |
Principal deposited in Trust Account | ||||||||
- | - | - | - | - | - | 0 | 0 | 250,000 |
Net cash used in investing activities | ||||||||
-111,329 | -86,318 | 350 | 27,277 | -26,179 | 153,050 | 214 | 451 | -250,000 |
Cash flows from financing activities: | ||||||||
Proceeds from borrowings on long-term debt and lines of credit | ||||||||
70,000 | - | - | - | 317,000 | - | - | - | - |
Repayments on long-term debt and lines of credit | ||||||||
984 | - | - | - | 151,916 | - | - | - | - |
Payments on capital leases | ||||||||
10,780 | - | - | - | 9,874 | - | - | - | - |
Proceeds from issuance of promissory note payable | ||||||||
- | - | - | - | 100,000 | - | 0 | 0 | 96 |
Proceeds from issuance of members' interests | ||||||||
- | - | - | - | 20,000 | - | - | - | - |
Repayment of notes payable to related parties | ||||||||
- | - | - | - | - | - | 0 | 0 | 270 |
Proceeds received from initial public offering | ||||||||
- | - | - | - | - | - | 0 | 0 | 250,000 |
Payments for equity issuance costs | ||||||||
- | - | - | - | 837 | - | 0 | 0 | 4,994 |
Payments of deferred financing costs | ||||||||
- | - | - | - | 9,027 | - | - | - | - |
Distributions to members | ||||||||
- | - | - | - | 250,000 | - | - | - | - |
Payment of contingent consideration | ||||||||
- | - | - | - | 12,000 | - | - | - | - |
Payments for redemption of members' interest | ||||||||
- | - | - | - | 3,713 | - | - | - | - |
Proceeds received from private placement | ||||||||
- | - | - | - | - | - | 0 | 0 | 6,500 |
Net cash provided by (used in) financing activities | ||||||||
58,234 | - | - | - | -368 | -202,562 | 0 | 0 | 251,331 |
Net change in cash and cash equivalents | ||||||||
-28,714 | 52,017 | -255 | 10,246 | -10,315 | - | - | - | - |
Deferred underwriting commissions charged to equity in connection with the initial public offering | ||||||||
- | - | - | - | - | - | 0 | 0 | 7,875 |
Deferred offering costs charged to equity upon completion of the initial public offering | ||||||||
- | - | - | - | - | - | 0 | 0 | 190 |
Value of common stock subject to possible redemption | ||||||||
- | - | - | - | - | - | -876 | 876 | 238,497 |
Change in value of common stock subject to possible redemption | ||||||||
- | - | - | - | - | - | 876 | -186 | 186 |
Supplemental disclosures: | ||||||||
Cash paid for interest | ||||||||
7,704 | - | - | - | 2,829 | - | - | - | - |
Cash paid for income taxes | ||||||||
2,085 | - | - | - | 39 | - | - | - | - |
Net change in cash | ||||||||
- | - | - | - | - | - | - | - | 950 |
Noncash investing and financing activities: | ||||||||
Equipment acquired under capital lease obligations | ||||||||
9,757 | - | - | - | 8,564 | - | - | - | - |
Unpaid equipment and other fixed asset purchases at end of year | ||||||||
7,814 | - | - | - | 11,073 | - | - | - | - |
Equity consideration issued in connection with an acquisition | ||||||||
6,248 | - | - | - | - | - | - | - | - |
Contingent purchase price in connection with acquisitions | ||||||||
- | - | - | - | 1,500 | - | - | - | - |
Seller note issued in connection with an acquisition | ||||||||
- | - | - | - | 2,000 | - | - | - | - |